Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 158,313Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2STRIDES PHARMA

02 2ALKEM LABS LTD

03 3ARCUTIS

04 2ASTRAZENECA

05 2AUROBINDO PHARMA LTD

06 2HETERO LABS LTD III

07 2MICRO LABS

08 2MSN

09 1NORVIUM BIOSCIENCE

10 1PRINSTON INC

11 2SENORES PHARMS

12 2TORRENT

13 2ZYDUS PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

RLD : No

TE Code : AB

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Approval Date : 2020-03-30

Application Number : 208247

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Strides Pharma Science

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

RLD : No

TE Code : AB

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Approval Date : 2023-06-20

Application Number : 208247

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Strides Pharma Science

03

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ROFLUMILAST

Brand Name : DALIRESP

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Approval Date : 2011-02-28

Application Number : 22522

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

04

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ROFLUMILAST

Brand Name : DALIRESP

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Approval Date : 2018-01-23

Application Number : 22522

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

05

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Approval Date : 2018-11-23

Application Number : 208213

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

06

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Approval Date : 2023-04-18

Application Number : 208213

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

07

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Approval Date : 2019-03-22

Application Number : 208180

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

08

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Approval Date : 2023-04-18

Application Number : 208180

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

09

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Approval Date : 2018-10-03

Application Number : 208236

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

10

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Approval Date : 2023-10-19

Application Number : 208236

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank